Cargando…

The Impact of Palliative Transurethral Resection of the Prostate on the Prognosis of Patients With Bladder Outlet Obstruction and Metastatic Prostate Cancer: A Population-Matched Study

Objective: This study aimed to evaluate the survival outcomes of patients with bladder outlet obstruction (BOO) and metastatic prostate cancer (mPCa) after having a palliative transurethral resection of the prostate (pTURP) surgery. Methods: We identified patients with mPCa between 2004 and 2016 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Kun, Song, Pan, Zhang, Jiahe, Yang, Luchen, Liu, Peiwen, Lu, Ni, Dong, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586220/
https://www.ncbi.nlm.nih.gov/pubmed/34778357
http://dx.doi.org/10.3389/fsurg.2021.726534
_version_ 1784597849471713280
author Fang, Kun
Song, Pan
Zhang, Jiahe
Yang, Luchen
Liu, Peiwen
Lu, Ni
Dong, Qiang
author_facet Fang, Kun
Song, Pan
Zhang, Jiahe
Yang, Luchen
Liu, Peiwen
Lu, Ni
Dong, Qiang
author_sort Fang, Kun
collection PubMed
description Objective: This study aimed to evaluate the survival outcomes of patients with bladder outlet obstruction (BOO) and metastatic prostate cancer (mPCa) after having a palliative transurethral resection of the prostate (pTURP) surgery. Methods: We identified patients with mPCa between 2004 and 2016 in the Surveillance, Epidemiology, and End Results (SEER) database. Patients who received pTURP and non-surgical therapy were identified. A propensity-score matching was introduced to balance the covariate. Kaplan–Meier analysis and COX regression were conducted to evaluate the overall survival (OS) and cancer-specific survival (CSS) outcomes. Results: A total of 36,003 patients were identified; 2,823 of them were in the pTURP group and 33,180 were in the non-surgical group. The survival curves of the overall cohort showed that the pTURP group was associated with worse outcomes in both OS (HR: 1.12, 95% CI: 1.07–1.18, p < 0.001) and CSS (HR: 1.08, 95% CI: 1.02–1.15, p = 0.004) compared with the non-surgical group. The mean survival time in the overall cohort of the pTURP group was shorter than the non-surgical group in both OS [35.13 ± 1.53 vs. 40.44 ± 0.59 months] and CSS [48.8 ± 1.27 vs. 55.92 ± 0.43 months]. In the matched cohort, the pTURP group had significantly lower survival curves for both OS (HR: 1.25, 95% CI: 1.16–1.35, p < 0.001) and CSS (HR: 1.23, 95% CI: 1.12–1.35, p < 0.001) than the non-surgical group. pTURP significantly reduced the survival months of the patients (36.49 ± 0.94 vs. 45.52 ± 1.23 months in OS and 50.1 ± 1.49 vs. 61.28 ± 1.74 months in CSS). In the multivariate COX analysis, pTURP increased the risk of overall mortality (HR: 1.19, 95% CI: 1.09–1.31, p < 0.001) and cancer-specific mortality CSS (HR: 1.23, 95% CI: 1.14–1.33, p < 0.001) compared with the non-surgical group. Conclusions: For mPCa patients with BOO, pTURP could reduce OS and CSS while relieving the obstruction.
format Online
Article
Text
id pubmed-8586220
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85862202021-11-13 The Impact of Palliative Transurethral Resection of the Prostate on the Prognosis of Patients With Bladder Outlet Obstruction and Metastatic Prostate Cancer: A Population-Matched Study Fang, Kun Song, Pan Zhang, Jiahe Yang, Luchen Liu, Peiwen Lu, Ni Dong, Qiang Front Surg Surgery Objective: This study aimed to evaluate the survival outcomes of patients with bladder outlet obstruction (BOO) and metastatic prostate cancer (mPCa) after having a palliative transurethral resection of the prostate (pTURP) surgery. Methods: We identified patients with mPCa between 2004 and 2016 in the Surveillance, Epidemiology, and End Results (SEER) database. Patients who received pTURP and non-surgical therapy were identified. A propensity-score matching was introduced to balance the covariate. Kaplan–Meier analysis and COX regression were conducted to evaluate the overall survival (OS) and cancer-specific survival (CSS) outcomes. Results: A total of 36,003 patients were identified; 2,823 of them were in the pTURP group and 33,180 were in the non-surgical group. The survival curves of the overall cohort showed that the pTURP group was associated with worse outcomes in both OS (HR: 1.12, 95% CI: 1.07–1.18, p < 0.001) and CSS (HR: 1.08, 95% CI: 1.02–1.15, p = 0.004) compared with the non-surgical group. The mean survival time in the overall cohort of the pTURP group was shorter than the non-surgical group in both OS [35.13 ± 1.53 vs. 40.44 ± 0.59 months] and CSS [48.8 ± 1.27 vs. 55.92 ± 0.43 months]. In the matched cohort, the pTURP group had significantly lower survival curves for both OS (HR: 1.25, 95% CI: 1.16–1.35, p < 0.001) and CSS (HR: 1.23, 95% CI: 1.12–1.35, p < 0.001) than the non-surgical group. pTURP significantly reduced the survival months of the patients (36.49 ± 0.94 vs. 45.52 ± 1.23 months in OS and 50.1 ± 1.49 vs. 61.28 ± 1.74 months in CSS). In the multivariate COX analysis, pTURP increased the risk of overall mortality (HR: 1.19, 95% CI: 1.09–1.31, p < 0.001) and cancer-specific mortality CSS (HR: 1.23, 95% CI: 1.14–1.33, p < 0.001) compared with the non-surgical group. Conclusions: For mPCa patients with BOO, pTURP could reduce OS and CSS while relieving the obstruction. Frontiers Media S.A. 2021-10-29 /pmc/articles/PMC8586220/ /pubmed/34778357 http://dx.doi.org/10.3389/fsurg.2021.726534 Text en Copyright © 2021 Fang, Song, Zhang, Yang, Liu, Lu and Dong. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Surgery
Fang, Kun
Song, Pan
Zhang, Jiahe
Yang, Luchen
Liu, Peiwen
Lu, Ni
Dong, Qiang
The Impact of Palliative Transurethral Resection of the Prostate on the Prognosis of Patients With Bladder Outlet Obstruction and Metastatic Prostate Cancer: A Population-Matched Study
title The Impact of Palliative Transurethral Resection of the Prostate on the Prognosis of Patients With Bladder Outlet Obstruction and Metastatic Prostate Cancer: A Population-Matched Study
title_full The Impact of Palliative Transurethral Resection of the Prostate on the Prognosis of Patients With Bladder Outlet Obstruction and Metastatic Prostate Cancer: A Population-Matched Study
title_fullStr The Impact of Palliative Transurethral Resection of the Prostate on the Prognosis of Patients With Bladder Outlet Obstruction and Metastatic Prostate Cancer: A Population-Matched Study
title_full_unstemmed The Impact of Palliative Transurethral Resection of the Prostate on the Prognosis of Patients With Bladder Outlet Obstruction and Metastatic Prostate Cancer: A Population-Matched Study
title_short The Impact of Palliative Transurethral Resection of the Prostate on the Prognosis of Patients With Bladder Outlet Obstruction and Metastatic Prostate Cancer: A Population-Matched Study
title_sort impact of palliative transurethral resection of the prostate on the prognosis of patients with bladder outlet obstruction and metastatic prostate cancer: a population-matched study
topic Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586220/
https://www.ncbi.nlm.nih.gov/pubmed/34778357
http://dx.doi.org/10.3389/fsurg.2021.726534
work_keys_str_mv AT fangkun theimpactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy
AT songpan theimpactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy
AT zhangjiahe theimpactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy
AT yangluchen theimpactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy
AT liupeiwen theimpactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy
AT luni theimpactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy
AT dongqiang theimpactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy
AT fangkun impactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy
AT songpan impactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy
AT zhangjiahe impactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy
AT yangluchen impactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy
AT liupeiwen impactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy
AT luni impactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy
AT dongqiang impactofpalliativetransurethralresectionoftheprostateontheprognosisofpatientswithbladderoutletobstructionandmetastaticprostatecancerapopulationmatchedstudy